Drug trial shows promise for less invasive treatment of rare foetal blood disease ...Middle East

New Delhi, Aug 8 (IANS) A new investigational drug, nipocalimab, has shown promising results in altering the standard treatment for Hemolytic Disease of the Fetus and Newborn (HDFN), potentially delaying or preventing anemia and reducing the need for intrauterine blood transfusions in high-risk pregnancies. HDFN is a severe condition where the blood types of a mother and her foetus are incompatible, leading to life-threatening anemia in the baby. Currently, treatment typically involves multiple ultrasound-guided intrauterine blood transfusions, which carry risks like fetal death, premature rupture of membranes, and pre-term birth. “If further studies support using nipocalimab to treat HDFN,

Hence then, the article about drug trial shows promise for less invasive treatment of rare foetal blood disease was published today ( Thursday 08/08/2024 - 01:36 PM ) and is available on News room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Drug trial shows promise for less invasive treatment of rare foetal blood disease )

Also on site :

• Rooster Runs Wild: Director Zach Braff Breaks Down Greg's Night Out In Episode 4 — And Working With John C. McGinley Across Two Shows
• Iranian academic describes US-Israeli attacks on Iran’s universities
• Meet the ex-Google CMO who quit with a seven-figure package by 28—he says getting promoted was easy because he just ‘disregarded all the rules’